IBM Touts Watson Health Imaging AI
Platform at RSNA
December 03, 2019
At the 105th RSNA Scientific Assembly
and Annual Meeting, IBM Watson Health highlighted its recent clients and
collaborations for its IBM Watson Health Imaging artificial intelligence
(AI) platform, a provider of innovative artificial intelligence,
enterprise imaging and interoperability solutions available through
multiple products and services trusted by medical professionals
"We are delighted to announce these collaborations at RSNA highlighting
our advancements in medical imaging globally," said Anne Le Grand,
General Manager, Imaging, Life Sciences and Oncology, IBM Watson Health.
"From helping clinicians to identify potential missed findings to seeing
a summary view of patient records quickly, our innovative technologies
are at the forefront of Watson Health's mission to help enable
clinicians to more effectively respond to the world's most pressing
Hardin Memorial Health First Provider to Use Patient Synopsis
In June 2019, Hardin Memorial Health (HMH) announced it would be the
first provider to use IBM Watson Imaging Patient Synopsis, which
provides a summary view of patients through analytics and extracts
insights from patient records to uncover underlying issues.
"Being the first in the world to 'go live' with IBM Watson Imaging
Patient Synopsis was an enormous milestone for the HMH team. This tool
is already helping to empower HMH to assist care givers in their
treatment of patients through the use of this revolutionary platform,"
said Dennis Johnson, HMH president and CEO. "We look forward to our
ongoing collaboration with IBM Watson Health as we continue to care for
more than 400,000 Central Kentuckians at our facilities."
IBM Watson Health Imaging Clinical Review 3.0 Launches in UK
On October 30 2019, Clinical Review 3.0 launched in the UK. The solution
is designed to analyze medical imaging studies and their associated
reports to identify potential missed findings, helping to facilitate
more comprehensive reports, which can potentially lead to higher quality
of care for the patient.
IBM Watson Health Imaging has recently engaged with Fortrus Ltd, to grow
upon the reseller's strong relationship with the UK public sector, which
includes a single supplier outcome-based Managed Services framework.
Guerbet Signs Exclusive Development Agreement for AI in Prostate Cancer
Guerbet, a global specialist in contrast agents and solutions for
diagnostic and interventional imaging, also recently signed an exclusive
joint development agreement to develop an artificial intelligence
software solution to support prostate cancer diagnostics and monitoring,
utilizing MR imaging. This deal extends their earlier collaboration
regarding liver cancer signed in January, 2018.
IBM Imaging AI Marketplace Launched
The IBM Imaging AI Marketplace is a single-source solution designed to
help simplify the complex process of locating, purchasing, deploying and
managing the vast array of AI imaging applications. The Imaging AI
Marketplace is carefully curated and contains only U.S. Food and Drug
Administration (FDA)-cleared solutions alongside Watson Health developed
AI solutions. It provides a single location for procurement through
deployment, simplifying complex and resource-draining processes, and can
be easily accessed via our iConnect™️Enterprise Archive.
Circle Cardiovascular Imaging
DiA Imaging Analysis Ltd.
4ways Healthcare Limited Adopts IBM Watson Health Imaging Merge PACS
a fast-growing private tele-radiology network in the UK that enables
UK-based radiologists to work remotely over a leading technology
platform, has committed to underpin its ambitious growth strategy with
IBM Watson Health's Merge PACS 8.0 platform, upgrading its current
platform to support their business growth. Merge PACS™ is a workflow
platform that is designed to help simplify physicians' reading
activities and can empower IT leaders with advanced control of the flow
of studies throughout the enterprise.
"We're committed to constantly investing in and upgrading our IT
provision to be able to offer our clients and partners the very best
service. That means working with the best tech providers in our space.
We've used Merge solutions successfully for many years so continuing
with IBM Watson Health imaging solutions was a natural next step. Merge
PACS is designed to handle high-enterprise imaging volumes, perform in
diverse reading environments, and helps us to scale our delivery of
care," said Ajay Chadha, CEO, 4ways.